Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Revolutionising diagnostics with some help from nature

Scientists question how humans' complex organisms, tools and systems work
 Shutterstock
Scientists question how humans' complex organisms, tools and systems work Shutterstock

Abstract:
Scientists from the EU-funded RECEPTRONICS project are turning to nature, and combining what they learn with the latest in nanotechnology, to find new ways of diagnosing cancer. The project, funded by the EU with EUR 1.99 million, brings together experts in the fields of biochemistry, bioengineering, nanotechnology and information technology.

Revolutionising diagnostics with some help from nature

Europe | Posted on December 23rd, 2008

As the old saying goes, there is no need to re-invent the wheel. Taking this to heart, scientists are borrowing a page from nature and are finding new ways of applying the way nature performs diagnoses to modern medicinal applications.

RECEPTRONICS project coordinator Professor Marco Tartagni of the University of Bologna (Italy) explains, 'The idea is to use bioengineering to harness the natural biological process for molecule recognition, and to put it together with state-of-the-art electronics.'

While the three-year project officially ended in September 2008, the partners are so enthused by the results they have already achieved that they have agreed to self-fund at least another year of working together.

According to the scientists, evolution has already provided the human body with a whole suite of tools that it can use to diagnose sickness. When the body contracts a cold or the flu, this is accompanied by a sore throat and a runny nose, for example. This is the body's way of telling us that we have the flu. A blocked nose is also an indication that the body is fighting back and already winning the battle. How this works, however, is extremely complicated, involving complex organisms, tools and systems which scientists are still struggling to understand, and hopefully one day, emulate.

RECEPTRONICS aims to develop a revolutionary new hybrid technology that will offer the possibility of detecting diseases right at inception. Hopefully within a few years they will have developed the technology which will enable every doctor's surgery to have a small, inexpensive device that can test blood on the spot and warn of impending illness before any symptoms become apparent.

At the heart of the process is molecule recognition, a process that a healthy human body performs continually. For medical purposes, the type of molecule which needs to be recognised is called a biomarker, and its presence can indicate a disease is starting well before there are any other symptoms. In order to recognise biomolecules, nature has developed receptors, which are mirror images of the molecules being sensed. Every single type of biomolecule has its own receptor in nature.

Professor Tartagni explains how their technology works: 'The front end of the system is composed of bioengineered receptors that are very similar to those generated by nature and specifically designed to target molecules, put together with man-made microelectronic systems at the back end. The results are very promising and we could soon unveil the best and most precise method ever developed of sensing single molecules.'

Professor Tartagni points out it could be months or even years after the first biomarkers have appeared before full-blown cancer develops. 'What is needed is a very smart sensor which can precisely detect concentrations of a wide range of molecules, and the only way to get the required precision is to count molecules one by one. Nature has developed a way to do this, and we are trying to do exactly what nature does,' he says.

'We have pioneered techniques which are working very well, and we now need to tie them together. We are working on a compact and affordable point-of-care biomarker detection device which can be made commercially available,' he says.

It is no exaggeration to say the techniques developed by the RECEPTRONICS researchers could truly revolutionise both diagnostics and the development of new medicines.

####

For more information, please click here

Copyright © European Commission

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

Biomimetics

Nanoribbons in solutions mimic nature: Rice University scientists test graphene ribbons' abilities to integrate with biological systems August 15th, 2016

IEEE ROBIO 2015 Call for Papers: 2015 IEEE International Conference on Robotics and Biomimetics - December 6-9, 2015, Zhuhai, China July 19th, 2015

Biomimetic dew harvesters: Understanding how a desert beetle harvests water from dew could improve drinking water collection in dew condensers December 8th, 2014

Peptoid Nanosheets at the Oil/Water Interface: Berkeley Lab Reports New Route to Novel Family of Biomimetic Materials September 3rd, 2014

Govt.-Legislation/Regulation/Funding/Policy

UT engineers develop first method for controlling nanomotors: Breakthrough for nanotechnology as UT engineers develop first method for switching the mechanical motion of nanomotors September 21st, 2018

Researchers develop microbubble scrubber to destroy dangerous biofilms September 19th, 2018

Researchers managed to prevent the disappearing of quantum information September 14th, 2018

New photonic chip promises more robust quantum computers September 14th, 2018

Nanomedicine

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

Sensors

UT engineers develop first method for controlling nanomotors: Breakthrough for nanotechnology as UT engineers develop first method for switching the mechanical motion of nanomotors September 21st, 2018

Leti Announces EU Project to Develop Powerful, Inexpensive Sensors with Photonic Integrated Circuits: REDFINCH Members Initially Targeting Applications for Gas Detection and Analysis For Refineries & Petrochemical Industry and Protein Analysis for Dairy Industry September 19th, 2018

Rice U. lab probes molecular limit of plasmonics: Optical effect detailed in organic molecules with fewer than 50 atoms September 5th, 2018

Measuring the nanoworld September 4th, 2018

Discoveries

Searching for errors in the quantum world September 21st, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

UT engineers develop first method for controlling nanomotors: Breakthrough for nanotechnology as UT engineers develop first method for switching the mechanical motion of nanomotors September 21st, 2018

Silver nanoparticles are toxic for aquatic organisms: A research team at the UPV/EHU-University of the Basque Country has analysed how zebrafish are affected in the long term by exposure to silver particles September 19th, 2018

Announcements

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals to Host R&D Day on Emerging Pipeline of RNAi Therapeutics September 25th, 2018

Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) September 25th, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project